Aug 02, 2023 9:10am EDT Lexaria’s Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD
Jul 28, 2023 9:10am EDT Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study
Jul 19, 2023 9:05am EDT Lexaria Granted Strategically Important New US Patent For DehydraTECH-Nicotine Including Oral Pouch Products
Jun 22, 2023 9:25am EDT Lexaria's Groundbreaking Research into DehydraTECH-CBD Published in International Journal of Molecular Science
Jun 16, 2023 9:10am EDT Lexaria’s DehydraTECH-CBD Lowers Blood Glucose Levels in Diabetes Animal Study
May 23, 2023 9:05am EDT Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers